PainTEQ Strengthens Leadership with New Clinical Appointment
PainTEQ, a pioneering medical device company, proudly announces the appointment of Dr. Lalit Venkatesan as its new Senior Vice President of Clinical Research. Dr. Venkatesan steps into this vital role amid growing recognition of the importance of innovative solutions for sacroiliac (SI) joint dysfunction.
Visionary Leadership in Clinical Research
In his new capacity at PainTEQ, Dr. Venkatesan will spearhead the clinical research strategy, focusing on generating robust evidence, promoting scientific communication, and overseeing clinical development initiatives. His leadership comes at a pivotal moment as the company looks to expand its portfolio of minimally invasive SI joint technologies.
Excitement for Transformative Change
"PainTEQ has a unique opportunity to help redefine how SI joint dysfunction is studied and treated," shared Dr. Venkatesan. His enthusiasm for joining the PainTEQ team reflects his commitment to constructing a solid and transparent clinical evidence foundation, supporting healthcare professionals in delivering impactful patient outcomes.
Dr. Venkatesan's Impressive Background
Bringing over a decade of experience in neuromodulation and medical device innovation, Dr. Venkatesan possesses substantial expertise in clinical strategy and evidence dissemination. He has recently held the position of Senior Director of Global Medical Affairs at Saluda Medical and previously contributed to clinical programs at Abbott Neuromodulation and Natus Medical.
Recognition and Accomplishments
His career is adorned with notable achievements, including the Volwiler Society Fellowship and the prestigious Abbott Chairman's Award. Furthermore, Dr. Venkatesan’s inclusion in Business Insider's list of "30 Under 40 MedTech Healthcare Leaders" speaks to his influence and leadership in the medtech space.
Support from Fellow Leaders
Corey Hunter, MD, Assistant Professor in the Department of Physical Medicine & Rehabilitation at Montefiore Medical Center, remarked, "Lalit brings a level of scientific rigor and strategic leadership that is essential for advancing credible clinical evidence in this space." His extensive background in neuromodulation and medical device research will undoubtedly enhance PainTEQ’s outreach and the quality of data available to physicians.
Commitment to Clinical Science and Patient Care
Shanth Thiyagalingam, the Chief Executive Officer of PainTEQ, expressed enthusiasm for Dr. Venkatesan’s arrival, stating, "We are thrilled to welcome Lalit to the PainTEQ leadership team. His expertise in global clinical research and evidence strategies will be critical as we bolster our efforts to promote responsible adoption of minimally invasive SI joint therapies." The diligence and innovative approaches instilled by Dr. Venkatesan are expected to advance PainTEQ’s mission of enhancing patient care through minimally invasive options.
About PainTEQ
Founded in 2013, PainTEQ is dedicated to developing interventional pain management solutions. With a specific focus on back pain and sacroiliac joint dysfunction, the company’s proprietary SI joint implant system has been effectively used in over 14,000 procedures, empowering patients with alternatives to manage chronic pain.
Frequently Asked Questions
What is PainTEQ known for?
PainTEQ specializes in interventional pain management, concentrating on solutions for back pain and sacroiliac joint dysfunction.
Who is Dr. Lalit Venkatesan?
Dr. Lalit Venkatesan is the new Senior Vice President of Clinical Research at PainTEQ, bringing extensive experience in neuromodulation and clinical strategy.
What will Dr. Venkatesan's role involve?
He will lead PainTEQ’s clinical research initiatives, focusing on evidence generation and the company's portfolio of minimally invasive technologies.
How many procedures have utilized PainTEQ's SI joint implant system?
To date, PainTEQ's proprietary SI joint implant system has been used in over 14,000 procedures worldwide.
What is PainTEQ's mission?
PainTEQ aims to enhance patient care through innovative, minimally invasive solutions for managing chronic pain.
